Mounjaro contains tirzepatide (a dual GIP/GLP-1 agonist by Eli Lilly) and Ozempic contains semaglutide (a GLP-1 agonist by Novo Nordisk)
Understanding this pharmacology is essential when evaluating treatment response, as the full therapeutic effect may not be apparent during the initial titration period
In their warning statement, the FDA said taking compounded GLP-1 drugs can be risky for patients because these drugs are not evaluated by the FDA for safety, effectiveness, and quality
Safety Concerns About Saxenda and Ozempic Saxenda and Ozempic have each been linked to gallbladder complications
Advanced neuroimaging studies could shed light on the specific neural pathways activated when sugar cravings decrease
If youre starting one of these anti-obesity medications, its important for you not to go into it blindly, advises registered dietitian Beth Czerwony, RD, LD